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We examined whether household use of antibacterial
cleaning and hygiene products is an emerging risk factor for
carriage of antimicrobial drug–resistant bacteria on hands of
household members. Households (N = 224) were random-
ized to use of antibacterial or nonantibacterial cleaning and
hygiene products for 1 year. Logistic regression was used to
assess the influence of antibacterial product use in homes.
Antibacterial product use did not lead to a significant
increase in antimicrobial drug resistance after 1 year (odds
ratio 1.33, 95% confidence interval 0.74–2.41), nor did it
have an effect on bacterial susceptibility to triclosan.
However, more extensive and longer term use of triclosan
might provide a suitable environment for emergence of
resistant species. Further research on this issue is needed.
Concern is growing over the use of household cleaningand hygiene products labeled as antibacterial as a
result of laboratory data showing a link between exposure
to ingredients in these products, particularly triclosan, and
emergence of antimicrobial drug resistance (1–3). This
study aimed to determine whether home use of antibacter-
ial cleaning and hygiene products (including use of a hand-
washing soap containing 0.2% triclosan) or other potential
risk factors was associated with carriage of antimicrobial
drug–resistant bacteria on household members’ hands. We
also assessed the association of these antibacterial prod-
ucts with carriage of organisms with reduced susceptibili-
ty to triclosan. 
Materials and Methods
Study Population
The data for this study were collected as part of a dou-
ble-masked and randomized home intervention trial (4);
participant enrollment began in October 2000, and follow-
up occurred for a 12-month period. The methods and ran-
domization procedures for this study have been reported
elsewhere (5). A total of 238 households were recruited at
baseline; 224 households completed the entire 1-year fol-
low-up (Figure 1). The study was approved by Columbia
University Medical Center Institutional Review Board. 
Intervention Methods
Households were supplied with over-the counter,
generically repackaged consumer cleaning and personal
hygiene products free of charge on a monthly or as-need-
ed basis. Households randomly assigned to use antibacter-
ial products received the following: 1) liquid handwashing
soap containing 0.2% triclosan, 2) liquid kitchen spray and
liquid all-purpose cleaner for hard surfaces that contained
a quaternary ammonium component, and 3) oxygenated
bleach laundry detergent. Households randomly assigned
to the nonantibacterial group received the same products
but without antibacterial ingredients. Both groups received
the same nonantibacterial liquid dishwashing detergent
and bars of body soap to control for potential use of other
products that might contain antibacterial ingredients.
Study participants were required to use only assigned
home hygiene products and were asked not to change any
of their normal hygiene practices. Participants, interview-
ers, and study coordinators were blinded to brand names
and ingredients in all products. Adherence to product treat-
ment group was assessed monthly, and products were
weighed during each visit to monitor compliance.
Households were immediately dropped from the study if
they did not adhere to randomized treatments.
Data Collection
At baseline, and quarterly during the 1-year period, a
trained interviewer collected demographic information
from the person self-identified as the primary caregiver in
the household. The baseline interview determined the type
of handwashing soap, hygiene, and cleaning products that
were used before randomization into the study (i.e., the
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brand and whether or not the ingredients were labeled as
antibacterial). The baseline and quarterly assessment
forms provided information such as the number and age of
household members, childcare attendance, symptoms of
infectious illnesses (fever, diarrhea, sore throat, vomiting,
conjunctivitis, skin boils, runny nose), antimicrobial drug
use, chronic diseases, self-rated health, birthplace, travel
outside of the United States, and occupation. In addition,
reported number of handwashes per day by the primary
caregiver and a timed observation of the handwash before
hand culturing were gathered. 
The hands of the primary caregiver were cultured dur-
ing the home visit at baseline and at the end of the 12-
month period before and after washing with the assigned
liquid handwashing product. The trained data collector
used a coin flip to choose the test hand, which was then
inserted into a sterile polyethylene bag containing 50 mL
culture medium (0.075 mol/L phosphate buffer, pH 7.9,
containing 0.1% polysorbate 80). The hand was massaged
for 1 min through the wall of the bag containing culture
medium. Only postwash samples were used in analyses
since they were considered to be representative of normal
versus transient flora found on hands.  
Laboratory Methods
The laboratory methods for this study have been
described previously (5,6). The microbiologic analysis and
antimicrobial drug–susceptibility testing were conducted
at New York Presbyterian Hospital, Columbia University
Medical Center, New York. Selective media were used to
isolate gram-positive cocci, gram-negative bacteria
(GNB), Staphylococcus aureus, and enterococci.
Only clinically important bacterial species that were
prevalent (species with >38 isolates recovered at baseline
and end of year combined) on the hands of homemakers
were selected for susceptibility analyses (7,8). These
included the following GNB: Acinetobacter baumannii, A.
lwoffi, Enterobacter agglomerans, E. cloacae, Klebsiella
pneumoniae, and Pseudomonas fluorescens/putida; and
the following gram-positive staphylococci: S. aureus, S.
warneri, S. epidermidis, and S. capitis. Therefore, only
persons who were carrying at least 1 of these organisms on
their hands were included in the final analyses (N = 164 at
baseline and N = 201 at year-end). No significant differ-
ences were noted between the measured demographic
characteristics (Tables 1 and 2 for listing of demographics)
among those included in the final analyses versus those
excluded (all p>0.10). 
Bacterial isolates were tested against a panel of antimi-
crobial agents by using MicroScan WalkAway 96 SI (Dade
Behring, Deerfield, IL, USA). Using the recommendations
of the Clinical and Laboratory Standards Institute (former-
ly NCCLS), we classified antimicrobial drug susceptibili-
ty as resistant, intermediate, or susceptible to a particular
antimicrobial agent (9). Organisms that tested as either
resistant or intermediately resistant to antimicrobial agents
were classified as “antibiotic resistant” (10). The selection
of antimicrobial agents to be tested for each organism was
based on clinical applicability of the antimicrobial drug
and consistency with earlier studies that examined a link
between triclosan and antimicrobial drug resistance
(11–14). GNB were tested against several antimicrobial
agents, and staphylococci were tested against oxacillin to
indicate methicillin resistance. For analytic purposes,
GNB species were classified as resistant if a given isolate
was resistant to >1 antimicrobial agent(s). 
Triclosan susceptibility was examined at Tufts
University School of Medicine, Boston, Massachusetts, by
using a modified NCCLS agar dilution method (10).
Minimum inhibitory concentration (MIC) was defined as
the lowest dilution of triclosan that inhibited visible
growth. A detailed description of antimicrobial drug and
triclosan testing, including controls used and MIC distribu-
tion for each organism, has been described previously (6).
Since data from the literature regarding triclosan suscepti-
bility testing are sparse and provide no standardized break-
points (6), we dichotomized triclosan MIC values for each
isolate by using the median MIC as a cutoff; low MIC rep-
resents less than or equal to the median value and high
MIC indicates greater than the median value. 
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Figure 1. Flow chart for randomized trial. After randomization and
loss to follow-up, the remaining study participants who carried
target organisms were included in the logistic regression analyses. 
Analytic Methods
First, chi-square and Student t tests were used to com-
pare demographic characteristics of antibacterial and
nonantibacterial users. Next, chi-square tests were used to
compare the overall proportion of antimicrobial
drug–resistant isolates found on the hands of the antibac-
terial and nonantibacterial groups. Finally, multivariate
logistic regression analyses were conducted to examine the
relationship between antibacterial product use and 2 sepa-
rate outcome variables: antimicrobial drug resistance
(measured by the presence of >1 antimicrobial drug–resist-
ant species on the hand) and increased triclosan MICs
(measured by the presence of >1 species exhibiting a tri-
closan MIC above the median value). 
Each potential covariate (i.e., characteristics of the
household and primary caregiver) and our 2 outcome vari-
ables were examined in univariate analyses to establish cri-
teria for inclusion in final multivariate models by using a p
value <0.05 as the cutoff. Covariates meeting the cutoff
criteria were included in multivariate models along with
the main effect of the randomized treatment (i.e., antibac-
terial versus nonantibacterial product use). Analyses were
conducted separately for baseline and after 1 year of study
participation. Unadjusted and adjusted odds ratios (OR)
and 95% confidence intervals (CIs) were generated from
logistic regression analyses by using SPSS V.10 (SPSS
Inc., Chicago, IL, USA). 
Results
GNB and staphylococci were recovered from 164 par-
ticipants at baseline and 201 participants at year-end. None
of the measured demographic and hygiene characteristics
differed significantly between the randomized groups (all
p>0.10) (Tables 1 and 2). When comparing isolates from
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the antibacterial users and nonantibacterial users (Figure 2
and online Appendix Figure, available from
http://www.cdc.gov/ncidod/EID/vol11no10/04-1276_
app.htm), no significant differences in the proportions of
resistance were found in all species combined or within
single species (all p>0.05).
The odds of carrying >1 antimicrobial drug–resistant
strain(s) among antibacterial product users and nonusers
were not significant at baseline (OR 0.97, 95% CI
0.50–1.89) or after 1 year of antibacterial product use (OR
1.33, 95% CI 0.74–2.41) (Table 3). In addition, the odds of
carrying >1 organism with high triclosan MIC among anti-
bacterial product users or nonusers were similar at baseline
(OR 1.59, 95% CI 0.84–3.01) and at year-end (OR 1.73,
95% CI 0.97–3.09). 
Individual and Household Characteristics 
and Susceptibility
At baseline, primary caregivers with higher than aver-
age CFU on their hands were twice as likely to carry
antimicrobial drug–resistant organisms (Table 3). A slight-
ly increased risk of carrying antimicrobial drug–resistant
organisms occurred among those who washed their hands
for a longer duration before the culture sample at baseline
(Table 3). However, longer duration of handwashing was
not associated with reduced bacterial CFU on hands (OR
1.02, 95% CI 0.99–1.06).
At year-end, both the number of times hands were
washed per day and the presence of any household mem-
ber(s) with a healthcare or daycare occupation were signif-
icantly associated with reduced carriage of antimicrobial
drug–resistant organisms on hands of the primary caregiv-
er (Table 3). Primary caregivers residing in households
with members working in healthcare or daycare were sig-
nificantly more likely to report above-average number of
handwashes per day (OR 3.05, 95% CI 1.71–5.44). None
of the other characteristics, such as health conditions or
antimicrobial drug use, were significantly associated with
carriage at baseline or after 1 year (all p>0.05).
Discussion
This study is the first randomized intervention study to
investigate the relationship between antibacterial cleaning
and hygiene product use and antimicrobial drug suscepti-
bility of hand microflora within the community setting.
Our earlier research, conducted among the same study
population described here, showed that use of antibacteri-
al hand soap containing 0.2% triclosan was no more bene-
ficial than plain soap in reducing infectious illness
symptoms or bacterial counts on hands of household mem-
bers (4,5,15). Several avenues of research have contributed
to the view that use of products containing triclosan may
foster the emergence of antimicrobial drug– or biocide-
resistant organisms. This concern stems from reports that
exposure to triclosan can lead to bacterial target mutations
conferring cross-resistance to isoniazid and selects for
mutants bearing resistance to various antimicrobial agents
through expression of multidrug-resistant efflux pumps
(12,16). Our findings suggest that household use of anti-
bacterial cleaning and hygiene products for a 1-year peri-
od is not a significant risk factor for increasing
antimicrobial drug–resistant organisms on the hands of
persons in the home.  
Few data compare resistance patterns among hand
microflora and susceptibility to antibacterial handwashing
ingredients. One recent cross-sectional study (17) reported
a higher prevalence of decreased susceptibility to triclosan
among methicillin-resistant S. epidermidis compared to
methicillin-sensitive S. epidermidis clinical isolates. The
findings reported in other cross-sectional studies have
mainly examined environmental and clinical isolates of
bacteria, and the correlations reported have been inconsis-
tent (11,13,18–20).
Other Factors Associated with 
Antimicrobial Drug Resistance
Several hygiene-related factors were significantly asso-
ciated with carriage, regardless of antibacterial product
use. Longer handwashes were slightly associated with
increased risk for carriage of antimicrobial drug–resistant
species at baseline; as reported previously, these findings
may be an artifact of sampling technique (5). The culture
was taken directly after the handwash; an increased
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Figure 2. Proportion of study participants with >1 bacterial species
resistant to an antimicrobial agent on their hands. In the group that
used antibacterial products, 82 and 105 hand samples were avail-
able at baseline and at year-end, respectively. In the group that
used nonantibacterial products (i.e., plain soap), 82 and 96 hand
samples were available at baseline and at year-end, respectively. 
duration of the wash may have allowed greater dispersal of
bacteria into the culture bag. 
Primary caregivers residing in households with health-
care or daycare workers had significantly fewer antimicro-
bial drug–resistant organisms on their hands. This
association appears to be influenced by above-average
number of handwashes per day by the primary caregiver
and indicates that hygiene, regardless of antibacterial
ingredients, may reduce household transmission of antimi-
crobial drug–resistant bacteria. 
Limitations for Detecting Changes in Resistance
A factor that might have attenuated the associations
found in this study is a higher baseline level of antimicro-
bial drug resistance in this community. Higher baseline
levels would make detecting small changes in susceptibil-
ity attributed solely to use of antibacterial cleaning and
hygiene products more difficult. Most persons from our
study population were from the Dominican Republic, a
country that provides over-the-counter access to antimicro-
bial agents. In an earlier study within this same communi-
ty, antimicrobial agents were taken by 354 (39%) of 911
persons reporting infectious disease symptoms within the
previous 30 days, which suggests high levels of use (21).
In addition, this study was conducted for a 1-year period
and therefore may not adequately reflect the time-course
for development of resistance attributable to use of anti-
bacterial products. Changes in antimicrobial drug resist-
ance during the 1-year period might have been lower than
the level of detection that this study was statistically pow-
ered to identify. This study was designed to detect an OR
>2.11 after 1 year of use, given a power of 80% and a 2-
sided α level of 0.05. 
Although triclosan susceptibility was examined among
various species, we were not able to evaluate potential
mechanisms for cross-resistance, such as overexpression
of efflux pumps. In addition, when we examined the asso-
ciation between use of antibacterial cleaning and hygiene
products and antimicrobial drug resistance, the definition
of resistance (>1 organism[s] with antimicrobial drug
resistance) did not allow exploration of the potential asso-
ciation with each separate species or antimicrobial drug
tested. However, the purpose of our study was to examine
overall trends and shifts in antimicrobial drug resistance
attributed to the use of antibacterial cleaning and hygiene
products, given that the effects of these products in the
community are relatively unexplored. 
Conclusion
Currently, no evidence suggests that use of antibacteri-
al soap containing 0.2% triclosan provides a benefit over
plain soap in reducing bacterial counts and rate of infec-
tious symptoms in generally healthy persons in the house-
hold setting (4,5,15). Our 1-year randomized community
intervention study adds to these earlier findings by assess-
ing the potential risks associated with antibacterial product
use in the home. The results from our study do not impli-
cate use of antibacterial cleaning and hygiene products as
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an influential factor in carriage of antimicrobial
drug–resistant bacteria on the hands of household mem-
bers. Although we did not observe a significant impact on
antimicrobial drug resistance during the 1-year period, a
longer duration and more extensive use of triclosan might
provide a suitable environment for emergence of antimi-
crobial drug–resistant species in the community setting.
Further surveillance for the effect of long-term use of anti-
bacterial cleaning and hygiene products on antimicrobial
drug resistance in the community is needed. 
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